Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
85.46
+1.61 (+1.92%)
Streaming Delayed Price
Updated: 11:32 AM EDT, Aug 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
98,814
Open
84.87
Bid (Size)
85.44 (2)
Ask (Size)
85.65 (2)
Prev. Close
83.85
Today's Range
83.92 - 85.67
52wk Range
55.02 - 98.40
Shares Outstanding
47,190,970
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
August 06, 2024
Via
Benzinga
Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript
August 05, 2024
AXSM earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Performance
YTD
+10.90%
+10.90%
1 Month
+2.20%
+2.20%
3 Month
+12.92%
+12.92%
6 Month
-9.10%
-9.10%
1 Year
+17.81%
+17.81%
More News
Read More
A Glimpse Into The Expert Outlook On Axsome Therapeutics Through 9 Analysts
August 05, 2024
Via
Benzinga
Why Axsome Therapeutics Stock Is Sinking Today
August 05, 2024
Via
The Motley Fool
Axsome Plunges On Wide Losses, But Its Biggest Moneymaker Tacks On 135% Growth
August 05, 2024
Via
Investor's Business Daily
Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 05, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Decoding 9 Analyst Evaluations For Axsome Therapeutics
July 18, 2024
Via
Benzinga
Should You Buy This Sinking Stock on the Dip?
June 27, 2024
Via
The Motley Fool
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
July 24, 2024
Via
Benzinga
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Via
InvestorPlace
15 Analysts Assess Axsome Therapeutics: What You Need To Know
June 05, 2024
Via
Benzinga
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
July 22, 2024
Via
Benzinga
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
July 15, 2024
Via
The Motley Fool
Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5
July 11, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The 3 Best Biotech Stocks to Buy in July 2024
July 05, 2024
Via
InvestorPlace
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
July 04, 2024
Via
InvestorPlace
Why Axsome Therapeutics Stock Is Sinking Today
June 11, 2024
Via
The Motley Fool
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
June 05, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
June 04, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
June 03, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics to Participate in Upcoming Investor Conferences
May 30, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
May 29, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting
May 28, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.